BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10645009)

  • 21. BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells.
    Nakuci E; Mahner S; Direnzo J; ElShamy WM
    Exp Cell Res; 2006 Oct; 312(16):3120-31. PubMed ID: 16860316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B-MYB is hypophosphorylated and resistant to degradation in neuroblastoma: implications for cell survival.
    Schwab R; Caccamo A; Bettuzzi S; Anderson J; Sala A
    Blood Cells Mol Dis; 2007; 39(3):263-71. PubMed ID: 17588787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of B-Myb during mouse embryogenesis.
    Sitzmann J; Noben-Trauth K; Kamano H; Klempnauer KH
    Oncogene; 1996 May; 12(9):1889-94. PubMed ID: 8649849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
    Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB
    Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specificity of cyclin D1 for androgen receptor regulation.
    Petre-Draviam CE; Cook SL; Burd CJ; Marshall TW; Wetherill YB; Knudsen KE
    Cancer Res; 2003 Aug; 63(16):4903-13. PubMed ID: 12941814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The FHA domain protein SNIP1 is a regulator of the cell cycle and cyclin D1 expression.
    Roche KC; Wiechens N; Owen-Hughes T; Perkins ND
    Oncogene; 2004 Oct; 23(50):8185-95. PubMed ID: 15378006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transactivation mediated by B-Myb is dependent on TAF(II)250.
    Bartusel T; Klempnauer KH
    Oncogene; 2003 May; 22(19):2932-41. PubMed ID: 12771944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical interaction between CDK9 and B-Myb results in suppression of B-Myb gene autoregulation.
    De Falco G; Bagella L; Claudio PP; De Luca A; Fu Y; Calabretta B; Sala A; Giordano A
    Oncogene; 2000 Jan; 19(3):373-9. PubMed ID: 10656684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of cyclin A/Cdk2 phosphorylation sites in B-Myb.
    Bartsch O; Horstmann S; Toprak K; Klempnauer KH; Ferrari S
    Eur J Biochem; 1999 Mar; 260(2):384-91. PubMed ID: 10095772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylation of B-Myb regulates its transactivation potential and DNA binding.
    Johnson TK; Schweppe RE; Septer J; Lewis RE
    J Biol Chem; 1999 Dec; 274(51):36741-9. PubMed ID: 10593981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The transcription factor B-Myb is maintained in an inhibited state in target cells through its interaction with the nuclear corepressors N-CoR and SMRT.
    Li X; McDonnell DP
    Mol Cell Biol; 2002 Jun; 22(11):3663-73. PubMed ID: 11997503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. D-type cyclins repress transcriptional activation by the v-Myb but not the c-Myb DNA-binding domain.
    Ganter B; Fu Sl; Lipsick JS
    EMBO J; 1998 Jan; 17(1):255-68. PubMed ID: 9427759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclin A1 directly interacts with B-myb and cyclin A1/cdk2 phosphorylate B-myb at functionally important serine and threonine residues: tissue-specific regulation of B-myb function.
    Müller-Tidow C; Wang W; Idos GE; Diederichs S; Yang R; Readhead C; Berdel WE; Serve H; Saville M; Watson R; Koeffler HP
    Blood; 2001 Apr; 97(7):2091-7. PubMed ID: 11264176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myb binding proteins: regulators and cohorts in transformation.
    Ness SA
    Oncogene; 1999 May; 18(19):3039-46. PubMed ID: 10378699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-Myb protein in cellular proliferation, transcription control, and cancer: latest developments.
    Sala A; Watson R
    J Cell Physiol; 1999 Jun; 179(3):245-50. PubMed ID: 10228942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of human B-MYB by cyclins.
    Sala A; Kundu M; Casella I; Engelhard A; Calabretta B; Grasso L; Paggi MG; Giordano A; Watson RJ; Khalili K; Peschle C
    Proc Natl Acad Sci U S A; 1997 Jan; 94(2):532-6. PubMed ID: 9012818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclin-dependent kinase-mediated phosphorylation and the negative regulatory domain of transcription factor B-Myb modulate its DNA binding.
    Wijeratne TU; Guiley KZ; Lee HW; Müller GA; Rubin SM
    J Biol Chem; 2022 Sep; 298(9):102319. PubMed ID: 35926712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mip/LIN-9 regulates the expression of B-Myb and the induction of cyclin A, cyclin B, and CDK1.
    Pilkinton M; Sandoval R; Song J; Ness SA; Colamonici OR
    J Biol Chem; 2007 Jan; 282(1):168-75. PubMed ID: 17098733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell cycle regulation by the B-Myb transcription factor.
    Joaquin M; Watson RJ
    Cell Mol Life Sci; 2003 Nov; 60(11):2389-401. PubMed ID: 14625684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression.
    Sala A; Calabretta B
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10415-9. PubMed ID: 1438227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.